Bioactivity | p-Aminophenylmercuric acetate is an organomercurial activator of matrix metalloproteinases (MMP). P-Aminophenylmercuric acetate participates in the activation and inhibition of MMP-8 by attacking protein sulfhydryl or inducing cysteine switching reaction. p-Aminophenylmercuric acetate promotes the shedding of betacellulin precursor (pro-BTC). p-Aminophenylmercuric acetate influences the binding of agonists and antagonists to the opiate receptor[1][2][3]. | ||||||||||||
Invitro | p-Aminophenylmercuric acetate (APMA) (0-30 µM;20 min) 减少了大鼠脑匀浆中二氢吗啡结合位点的数量,增加了激动剂对结合钠抑制作用的敏感性[2]。p-Aminophenylmercuric acetate (0.5 mM;30 min) 激活基质金属蛋白酶 2 和 9[3]。 | ||||||||||||
Name | p-Aminophenylmercuric acetate | ||||||||||||
CAS | 6283-24-5 | ||||||||||||
Formula | C8H9HgNO2 | ||||||||||||
Molar Mass | 351.75 | ||||||||||||
Appearance | Solid | ||||||||||||
Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
Storage |
|
||||||||||||
Reference | [1]. Sanderson M P, et al. ADAM10 mediates ectodomain shedding of the betacellulin precursor activated by p-aminophenylmercuric acetate and extracellular calcium influx[J]. Journal of Biological Chemistry, 2005, 280(3): 1826-1837. [2]. PASTERNAK G W, et al. Differential effects of protein-modifying reagents on receptor binding of opiate agonists and antagonists[J]. Molecular Pharmacology, 1975, 11(3): 340-351. [3]. Gendron R, et al. Inhibition of the activities of matrix metalloproteinases 2, 8, and 9 by chlorhexidine[J]. Clinical Diagnostic Laboratory Immunology, 1999, 6(3): 437-439. |